Cancer cause control:! Can prevent liver cancer!

September 25, 2018 / BIOON / - according to a new study published in cancer causes & control, a drug commonly used to treat type 2 diabetes may prevent patients from developing liver cancer Photo source: Cancer Causes & Control in this study, Dr Harvey J murff and colleagues found that patients taking metformin for type 2 diabetes had a lower risk of liver cancer than those taking other drugs Although previous studies have found that metformin is associated with a lower incidence rate of some types of cancer, most studies are affected by differences in treatment time and confounding factors, such as BMI and blood sugar control In this study, the researchers carefully controlled these factors, and their data came from the National Veterans' health management database They found that apart from the incidence rate of liver cancer, metformin and 10 other solid tumors were not associated with incidence rate Their work suggests that researchers should further study the role of metformin in the prevention of liver cancer Reference: Harvey J murff et al Measurement use and include cancer risk: evidence for a selective protective effect against life cancer, cancer causes & Control (2018) Doi: 10.1007/s10552-018-1058-4